Wuxi AppTec Co (SHSE:603259) FCF Margin % : 11.14% (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Wuxi AppTec Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Wuxi AppTec Co's Free Cash Flow for the three months ended in Dec. 2023 was ¥1,203 Mil. Wuxi AppTec Co's Revenue for the three months ended in Dec. 2023 was ¥10,799 Mil. Therefore, Wuxi AppTec Co's FCF Margin % for the quarter that ended in Dec. 2023 was 11.14%.

As of today, Wuxi AppTec Co's current FCF Yield % is 6.26%.

The historical rank and industry rank for Wuxi AppTec Co's FCF Margin % or its related term are showing as below:

SHSE:603259' s FCF Margin % Range Over the Past 10 Years
Min: -10.25 Med: 2.32 Max: 19.51
Current: 19.51

During the past 10 years, the highest FCF Margin % of Wuxi AppTec Co was 19.51%. The lowest was -10.25%. And the median was 2.32%.

SHSE:603259's FCF Margin % is ranked better than
90.18% of 224 companies
in the Medical Diagnostics & Research industry
Industry Median: -10.51 vs SHSE:603259: 19.51

Wuxi AppTec Co FCF Margin % Historical Data

The historical data trend for Wuxi AppTec Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuxi AppTec Co FCF Margin % Chart

Wuxi AppTec Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

2.98

5.70

-10.25

1.65

19.51

Wuxi AppTec Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-2.85	19.61	14.39	32.65	11.14

Competitive Comparison of Wuxi AppTec Co's FCF Margin %

For the Diagnostics & Research subindustry, Wuxi AppTec Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wuxi AppTec Co's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Wuxi AppTec Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Wuxi AppTec Co's FCF Margin % falls into.

Wuxi AppTec Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Wuxi AppTec Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	7870.353	/	40340.807
	=	19.51 %

Wuxi AppTec Co's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	1203.28	/	10799.481
	=	11.14 %

Wuxi AppTec Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Wuxi AppTec Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Wuxi AppTec Co (SHSE:603259) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Wuxi AppTec Co Ltd (SHSE:603259) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

WUXIF:USA WUXAY:USA 02359:Hong Kong WX8:Germany

Address

288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, CHN, 200131

Website

https://www.wuxiapptec.com

Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services through the discovery, development, and manufacturing spectrum for small-molecule drugs, cell therapies, and gene therapies as well as providing testing services for medical devices. Its segments comprise China-based laboratory services; U.S.-based laboratory services; Clinical research and other CRO services; CDMO services; and Others. The majority of revenue gets derived from China-based laboratory services that include small molecules discovery, such as synthetic chemistry, medicinal chemistry, analytical chemistry, biology, drug metabolism and pharmacokinetics (DMPK)/absorption, distribution, metabolism, and excretion (ADME), toxicology and bioanalytical services.

Wuxi AppTec Co (SHSE:603259) Headlines

No Headlines